Literature DB >> 17313122

Laparoscopic splenectomy is a better treatment for adult ITP than steroids--it should be used earlier in patient management. Conclusions of a ten-year follow-up study.

L R Khan1, S J Nixon.   

Abstract

BACKGROUND: Laparoscopic splenectomy (LS) has rapidly become the preferred surgical treatment for immune thrombocytopaenic purpura (ITP). The aim of this study was to assess the long-term outcome of laparoscopic splenectomy for adult ITP performed in a single unit.
METHODS: Between 1992 and 2002, 55 patients underwent LS for ITP refractory to medical therapy. These were performed by one surgeon. Long-term outcome data was obtained by case note review and telephone-based questionnaire. Complete remission was defined as a sustained platelet count of >100 x 10(9)/L without further requirement for medical therapy.
RESULTS: Follow-up information was obtained for 40 (73%) out of 55 patients. Overall, 35 (88%) of 40 patients were in complete remission at five-year median follow-up. Five (13%) patients required continued steroid therapy despite LS. Seven (18%) patients reported bleeding problems, in particular bruising. Thirty-five (88%) of 40 patients considered their operation a success. Of these, 16 (46%) patients wished that the operation had been performed earlier in the course of their disease.
CONCLUSIONS: This ten-year experience demonstrates that LS is safe, effective, and yields excellent long-term results for adult ITP, equivalent to results after open splenectomy. Patients' views suggest that laparoscopic splenectomy should be considered sooner in the management of adult ITP, reducing the duration and morbidity of medical treatment.

Entities:  

Mesh:

Year:  2007        PMID: 17313122     DOI: 10.1016/s1479-666x(07)80105-3

Source DB:  PubMed          Journal:  Surgeon        ISSN: 1479-666X            Impact factor:   2.392


  4 in total

1.  Laparoscopic splenectomy: the clinical practice guidelines of the European Association for Endoscopic Surgery (EAES).

Authors:  B Habermalz; S Sauerland; G Decker; B Delaitre; J-F Gigot; E Leandros; K Lechner; M Rhodes; G Silecchia; A Szold; E Targarona; P Torelli; E Neugebauer
Journal:  Surg Endosc       Date:  2008-02-22       Impact factor: 4.584

2.  Impact of chronic Immune Thrombocytopenic Purpura (ITP) on health-related quality of life: a conceptual model starting with the patient perspective.

Authors:  Susan D Mathias; Sue K Gao; Kimberly L Miller; David Cella; Claire Snyder; Ralph Turner; Albert Wu; James B Bussel; James N George; Robert McMillan; Diane Kholos Wysocki; Janet L Nichol
Journal:  Health Qual Life Outcomes       Date:  2008-02-08       Impact factor: 3.186

3.  Laparoscopic splenectomy in patients with idiopathic thrombocytopenic purpura and very low platelet count.

Authors:  Abbas Abdollahi; Seyed Maryam Naghibi; Hamed Shariat Razavi; Alireza Tavassoli; Azadeh Jabbari Nooghabi; Mehdi Jabbari Nooghabi
Journal:  Caspian J Intern Med       Date:  2022

Review 4.  Laparoscopic splenectomy: Current concepts.

Authors:  Evangelos P Misiakos; George Bagias; Theodore Liakakos; Anastasios Machairas
Journal:  World J Gastrointest Endosc       Date:  2017-09-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.